This site uses cookies. By using this site you agree to receiving cookies. View Policy.

178%

ioLight is the only pocket microscope with good enough resolution for scientists to see individual cells. It has been used in The Amazon Rainforest, Kazakhstan, Antarctica and at 5,000m on Mount Everest. The founders have sold nearly 300 units globally and are ready to grow the team and scale to volume.

  • $8BN market. ioLight sales are 60% export, 25% USA
  • 300 units sold to Universities, USDA, Eden Project, Bayer...
  • Filmed by National Geographic at 5000m on Mount Everest
  • One patent granted another pending

Idea

Scientists globally are monitoring climate change. They go to the most remote, fragile ecosystems and watch the smallest, most vulnerable plants and animals. They need a portable microscope. ioLight has patented a pocket digital microscope that records 1-micron (1/1000 mm) resolution images on a standard mobile phone. That's powerful enough to display single cells. ioLight images can be shared instantly from the phone to collaborators anywhere in the world.

ioLight is disrupting the $8BN microscope market. We believe that at least £50M of this is available to portable products and there is little competition in this sector. As well as climate change, this sector includes remote diagnostics of animals, fish, humans and plants and also lab applications where space is limited.

Andrew Monk and Richard Williams founded ioLight and patented the microscope in 2014. We funded on Crowdcube in 2015, commencing product sales in 2016. Our second Crowdcube round in 2017 recruited global sales channels and a PR team driving sales to almost 300 units. In 2019 National Geographic filmed the ioLight microscope monitoring the impact of Climate Change at 5000m meters on Mount Everest - one of the first times scientific measurements have been made at this altitude. We filed a second patent application for a portable XY stage in 2020 which would give our customers lab precision anywhere in the world.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

To see the rest of the ioLight Magnificent Mobile Microscopes pitch, join now. It's free, quick and easy.

Due to financial regulations, you need to join our community to view the full investment opportunity.

Join

Already registered? Log in

Risk warning

Investments of this nature carry risks to your capital, including illiquidity, lack of dividends and dilution. Balance risk with a diversified portfolio. Read more. Approved as a financial promotion by Crowdcube Capital Limited, which is authorised and regulated by the Financial Conduct Authority.

Investment opportunities are not offers to the public and investors must be eligible Crowdcube members. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions. Please seek independent advice as required as Crowdcube does not give investment or tax advice.

ioLight Magnificent Mobile Microscopes has been given advance assurance by HMRC that the proposed share issue is likely to qualify for Enterprise Investment Scheme (EIS) tax relief.

Tax relief is available to individuals only, with income tax relief currently set at 30 per cent of the cost of the shares for the tax year in which the investment was made. The tax reliefs can also reduce your Capital Gains Tax bill. Read More.

Availability of tax relief depends on your individual and the company’s ongoing circumstances and applicable law.